Cogent Biosciences, Inc. (NASDAQ:COGT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert J Perez Other companies: Rapport Therapeutics, Inc. (Director · Since at least Nov 7, 2024); Immunocore Holdings plc (Director · Jan 2, 2024 – Jan 2, 2024 · Past); Third Harmonic Bio Inc. (Director · Sep 14, 2022 – Mar 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 22, 2023 · Past); Spark Therapeutics Inc (Director · Jan 3, 2018 – Dec 17, 2019 · Past); Larimar Therapeutics, Inc. (Director · Sep 24, 2015 – Jun 26, 2019 · Past); Decoy Therapeutics Inc. (Director · Sep 2, 2015 – Jul 26, 2017 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 22, 2017 · Past); AMAG Pharmaceuticals Inc (Director · Jan 26, 2009 – May 16, 2019 · Past); Cubist Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 3, 2006 – Jan 21, 2015 · Past) | Director · Mar 28, 2018 – Jun 14, 2019 · Past |
| Arlene Morris Other companies: Edgewise Therapeutics, Inc. (Director · Since at least May 6, 2024); Palatin Technologies, Inc. (Director · Since at least Jun 22, 2022); Viridian Therapeutics, Inc. (Chief Executive Officer, Willow Advisors · Since at least Jun 8, 2022); Viveve Medical, Inc. (Director · Jan 3, 2023 – Jan 3, 2023 · Past) | Director · Since at least Jun 7, 2022 |
| Chris Cain Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Nov 10, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Viridian Therapeutics, Inc. (Director · Since at least Mar 10, 2025) | Director · Since at least Jul 6, 2020 |
| Matthew Ros Other companies: Verastem, Inc. (Chief Operating Officer · Jan 14, 2025 – Nov 4, 2026 · Past); Epizyme Inc (See Remarks · May 16, 2016 – Aug 16, 2021 · Past) | Pharma-Biotech Executive · Since at least Jul 26, 2019 |
| Peter Harwin Other companies: Oruka Therapeutics, Inc. (Director · Since at least Nov 5, 2026); Damora Therapeutics, Inc. (Chairman of the Board · Since at least May 12, 2026) | Founding Partner, Fairmount Funds Management LLC · Since at least Nov 4, 2026 |
| Chris Cain Other companies: Jade Biosciences, Inc. (Director of Research, Fairmount · Since at least Nov 4, 2026) | Member of the Compensation Committee, Chair of the Science & Technology Committee · Since at least Nov 4, 2026 |
| John Green Other companies: Merrimack Pharmaceuticals Inc (Principal Accounting Officer · Jun 14, 2017 – Jun 14, 2017 · Past) | Chief Financial Officer · Since at least Jan 31, 2019 |
| Jorn Aldag Other companies: Hookipa Pharma Inc (Chief Executive Officer, Director · Apr 17, 2019 – Apr 15, 2024 · Past) | Director · Mar 28, 2018 – Jul 1, 2020 · Past |
| Karen Ferrante Other companies: MacroGenics, Inc. (Director · Since at least May 13, 2021) | Director · Since at least Oct 1, 2020 |
| Todd Shegog Other companies: Forma Therapeutics Holdings Inc (SVP, Chief Financial Officer · Jun 18, 2020 – Oct 14, 2022 · Past) | Pharma-Biotech Executive · Since at least Feb 22, 2021 |
| Andrew Robbins | Chief Executive Officer & President · Since at least Dec 17, 2025 |
| Brad Barnett | Chief Technology Officer · Since at least Nov 5, 2026 |
| Charles Wilson | Chief Executive Officer, Director · Mar 28, 2018 – Mar 1, 2019 · Past |
| Christi Waarich | Senior Director, Investor Relations · Since at least Sep 15, 2026 |
| Cole Pinnow | Chief Commercial Officer · Since at least Dec 17, 2025 |
| Erin Schellhammer | Chief People Officer · Since at least Nov 5, 2026 |
| Evan Kearns | Chief Legal Officer · Since at least Jan 23, 2024 |
| Geoffrey Hodge | Chief Technical Officer · Mar 1, 2019 – Feb 11, 2020 · Past |
| Jessica Sachs | Chief Medical Officer · Since at least Nov 5, 2026 |
| John Robinson | Chief Scientific Officer · Since at least Mar 31, 2021 |